Protein tyrosine kinases in dendritic cell-mediated anti-cancer immunity

Seminars in Immunology · Published 2026-06-08 · DOI 10.1016/j.smim.2026.102037

Free full text

Authors (5)

Misha Mao, Liwei Zhao, Guido Kroemer, Oliver Kepp, Peng Liu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Mao, M., Zhao, L., Kroemer, G., et al. (2026). Protein tyrosine kinases in dendritic cell-mediated anti-cancer immunity. Seminars in Immunology. https://doi.org/10.1016/j.smim.2026.102037

Related articles

• Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges · Seminars in Immunology · 2025 · Same journal
• From immunobiology to intervention: Pathophysiology of autoimmune encephalitis · Seminars in Immunology · 2025 · Same journal
• Global aspects of celiac disease and food allergy · Seminars in Immunology · 2025 · Same journal
• Antiviral humoral immunity: Enemy or ally of viral immunotherapy? · Seminars in Immunology · 2025 · Same journal
• Three’s company: The cooperative signals behind the differentiation of Th9 cells · Seminars in Immunology · 2025 · Same journal
• Autoimmune diabetes and targets for immunomodulation · Seminars in Immunology · 2025 · Same journal
• The multifaceted role of B lymphocytes in type 1 diabetes · Seminars in Immunology · 2026 · Same journal
• Reovirus oncolysis and the next frontiers for this unique oncoviral immunotherapy · Seminars in Immunology · 2025 · Same journal
• Emerging roles of IL-9 and Th9 cells in respiratory viral illnesses · Seminars in Immunology · 2026 · Same journal
• Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity · Seminars in Immunology · 2025 · Same journal